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Results 
A significant difference in net survival between women diagnosed in 
New South Wales and the West Midlands (Figure 2) 
Survival for screen-detected women similar (Figure 3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Differences smaller for women who had attended screening (Figure 4)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Lead time adjusted estimates lower (Figure 5) 
Non-significant survival difference between New South Wales and West 
Midlands in adjusted estimates (Figure 6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Excess hazard ratios: regional differences in survival were greatest 
during the first three years following diagnosis (Figure 7). 
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Introduction 
 Our previous results: a significant difference in five-year breast 
cancer survival between Australia and England of 6% in the screening 
age group for women diagnosed during the period 1996-19991 
One possible explanation: relatively low intensity of breast screening 
in England compared to Australia 
 
Material 
Women aged 50 years or younger on 1st January 1996 
 Diagnosed with a primary invasive breast cancer during the period 1 
January 1996 to 31 December 2006 
 5,717 women from West Midlands region of England  
 6,396 women New South Wales, Australia 
 All women were followed up to 31 December 2006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cancer registry data  
Individual registry records linked to individual screening records  
Categories for screening status at diagnosis: screen-detected, interval 
cancer, lapsed attender, non-attender 
Conclusions 
Survival remains higher in New 
South Wales compared to the 
West Midlands for women aged 
50-64  
Survival differences less marked 
for women who have attended 
screening 
Non-significant difference in 
survival amongst screen–
detected women after adjustment 
for lead time 
Figure 4: Net survival estimates by screening category 
a) West Midlands     b) New South Wales 
Figure 1 – title 
Methods 
Non-parametric net survival estimates using the Pohar-Perme 
estimator2, using stns (software available for Stata 123)  
Comparison of the Pohar-Perme estimates with widely used Estève 
approach4;5 
Excess hazard and hazard ratios derived from survival 
Expected survival from regional life tables (single years of age for 
each year of follow-up) 
Adjustment for the potential effect of lead time bias: 
• calculation of adjusted survival time E(s) 6  
• mean sojourn time of 4 years  
• 10 simulated data sets: E(s)1, E(s)2 … E(s)10 assuming survival 
exponentially distributed with a mean of E(s) 
• survival estimates derived from these 10 separate data sets 
recombined using rules from the multiple-imputation setting7 
 
 
 
 
Figure 1 – Cohort included in analyses 
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Figure 2: Net survival estimates:  Figure 3: Net survival estimates: 
West Midlands and New South Wales  Screen-detected vs. non-screened 
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Figure 5: Estimates adjusted for   Figure 6: Adjusted net survival 
lead time bias: West Midlands   estimates: screen-detected cancers 
Differential survival in the non-screen detected groups may be due to 
women obtaining mammography privately in New South Wales 
Poorer treatment of non-screen detected women after their diagnosis 
remains one explanation for poorer survival in West Midlands 
 
Figure 7: Excess hazard ratios comparing 
lead-time adjusted hazard in screened  
group with the non-screened group   
